Logo image
Conformational landscape of soluble α-klotho revealed by cryogenic electron microscopy
Preprint   Open access

Conformational landscape of soluble α-klotho revealed by cryogenic electron microscopy

Nicholas J Schnicker, Zhen Xu, Mohammad Amir, Lokesh Gakhar and Chou-Long Huang
bioRxiv : the preprint server for biology
03/06/2024
DOI: 10.1101/2024.03.02.583144
PMCID: PMC10942382
PMID: 38496408
url
https://doi.org/10.1101/2024.03.02.583144View
Preprint (Author's original)This preprint has not been evaluated by subject experts through peer review. Preprints may undergo extensive changes and/or become peer-reviewed journal articles. Open Access

Abstract

α-Klotho (KLA) is a type-1 membranous protein that can associate with fibroblast growth factor receptor (FGFR) to form co-receptor for FGF23. The ectodomain of unassociated KLA is shed as soluble KLA (sKLA) to exert FGFR/FGF23-independent pleiotropic functions. The previously determined X-ray crystal structure of the extracellular region of sKLA in complex with FGF23 and FGFR1c suggests that sKLA functions solely as an on-demand coreceptor for FGF23. To understand the FGFR/FGF23-independent pleiotropic functions of sKLA, we investigated biophysical properties and structure of apo-sKLA. Mass photometry revealed that sKLA can form a stable structure with FGFR and/or FGF23 as well as sKLA dimer in solution. Single particle cryogenic electron microscopy (cryo-EM) supported the dimeric structure of sKLA. Cryo-EM further revealed a 3.3Å resolution structure of apo-sKLA that overlays well with its counterpart in the ternary complex with several distinct features. Compared to the ternary complex, the KL2 domain of apo-sKLA is more flexible. 3D variability analysis revealed that apo-sKLA adopts conformations with different KL1-KL2 interdomain bending and rotational angles. The potential multiple forms and shapes of sKLA support its role as FGFR-independent hormone with pleiotropic functions. A comprehensive understanding of the sKLA conformational landscape will provide the foundation for developing klotho-related therapies for diseases.
Fibroblast growth factor (FGF) monomer Soluble alpha-klotho (sKLA) dimer ternary complex 3D variability analysis (3DVA) cryogenic electron microscopy (cryo-EM)

Details

Metrics

70 Record Views
Logo image